Related Experiment Video
Updated: Aug 11, 2026

Electrochemiluminescence Assays for Human Islet Autoantibodies
Published on: March 23, 2018
C-reactive protein as an early predictor of gestational diabetes mellitus
Rosario D'Anna1, Giovanni Baviera, Antonio De Vivo
1Department of Obstetrics and Gynecology, University of Messina, Messina, Italy.
Objective:
To assess whether C-reactive protein at the beginning of the midtrimester is significantly increased in patients who subsequently develop gestational diabetes mellitus (GDM).
Study Design:
A total of 72 subjects who underwent a Down screening program between the 14th and 16th weeks of gestation were studied: 32 developed GDM, and 40 were controls. The C-reactive protein serum levels were evaluated in all patients.
Results:
There was a significant difference in body mass index (BMI) mean values between the GDM group (30.8 +/- 8.5) and control group (24.7 +/- 2.8), but in spite of this, no significant difference in C-reactive protein was found in the 2 groups. The median serum C-reactive protein values were 9.0 mg/dL (2.4-17, 5-95% CI) in the GDM group and 8.7 mg/dL (3.8-11.2, 5-95% CI) in the control group (p = 0.3). There was no correlation between C-reactive protein serum levels and BMI, birth weight or fasting insulin.
Conclusion:
C-reactive protein has no predictive value in GDM, and no positive correlation is found between BMI and this inflammation marker.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Hyperglycemia
Diabetic Retinopathy
Type I Diabetes I: Introduction
